Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478091 | 12647809 | 1 | I | 20160524 | 0 | 20160811 | 20160811 | DIR | 67.00 | YR | M | N | 113.50000 | KG | 20160720 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478091 | 12647809 | 1 | PS | IPILIMUMAB | IPILIMUMAB | 1 | Y | D | 0 | ||||||||||
| 126478091 | 12647809 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | Y | D | 0 | 300 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126478091 | 12647809 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126478091 | 12647809 | Melanoma recurrent | |
| 126478091 | 12647809 | Metastatic neoplasm | |
| 126478091 | 12647809 | Pruritus | |
| 126478091 | 12647809 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126478091 | 12647809 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126478091 | 12647809 | 1 | 20160501 | 20160524 | 0 | |
| 126478091 | 12647809 | 2 | 20150701 | 20160524 | 0 |